LORAZEPAM SUBLINGUAL
LORAZEPAM SUBLINGUAL
Approved
DIN Number
02410753
Drug Class
Human
Market Date
Oct 16, 2013
Company
HC
aa pharma inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02410753
AIG Number0110731001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA06 LORAZEPAM
Product Specifications
Dosage FormTablet
Route of AdministrationSublingual
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LORAZEPAMActive
Strength: 1 MG
Monograph: LORAZEPAM